Menü schließen

Blog

Strong cooperation for clinical trials

Let’s start together to define new goals in patient care and innovative research !!! https://www.linkedin.com/posts/research-experts-alliance-gmbh-co-kg-berlin_partners-clinical-trial-recruitment-management-activity-6860130177683361792-FjP3

Clinical research: complex research projects vs. industry standard vs. shortage of specialists

In addition to the emerging digitalization and centralization/decentralization of study processes, it has once again become clear since the Corona pandemic: skilled workers are disproportionately needed. For years, there has been a shortage of personnel in the research environment, giving large service structures the security to market themselves effectively. Over the years, industry has shaped

Read more

Individual study concepts: Creating added value for young, growing research companies!

An essential task in innovative clinical research is to move away from industry standards and create sustainability for research goals. Based on many years of practice, it is evident that complex indications and special requirements for certain patient populations are difficult to serve with standard processes. Innovative medicine develops holistic solutions for the prevention, diagnosis,

Read more

Cooperation: Capital for young and small medical companies from innovative sources

Research Experts Alliance from Berlin and the consulting firm for digital project and corporate finance StructuredStrategy from Hamburg want to jointly help pharmaceutical, medical technology and biotechnology companies achieve successful market development. The consulting companies StructuredStrategy from Hamburg and Research Experts Alliance from Berlin have agreed on a strategic cooperation. While Research Experts Alliance (REA)

Read more

PRESSE: starting-up “Start-up-Power für Medizin-Start-ups”

Wir freuen uns, dass die Redaktion von “starting-up” über uns Berichtet und hervorhebt, wie wichtig eine professionelle Unterstützung beim Start einer Studie ist, um mit einem Medizinprodukt am Markt auch wirklich erfolgreich zu sein. Hier geht es zum Artikel: https://www.starting-up.de/geschaeftsideen/gruenderstorys/start-up-power-fuer-medizin-start-ups.html

PRESSE: Electronic Commerce Info Net 14.04.2021

Wir freuen uns, dass die Redaktion vom “Electronic Commerce Info Net” über unser Konzept berichtet und betont, dass wir vor allem Start-Ups und kleine und mittelständische Unternehmen bei ihren Medizinprodukte- und pharmakologischen Studien in allen Phasen einer klinischen Studie begleiten! Hier geht es zum Artikel: https://www.ecin.de/anbieter/meldung/23759-research-experts-alliance-will-die-klinische-forschung-revolutionieren.html

Answers to your many questions…

What exactly is REA and what does REA stand for? The Research Experts Alliance (REA) GmbH & Co KG specializes in individual and innovative solutions for the implementation of clinical studies in the pharmaceutical industry, biotechnology and medical device technology. To do this, we rely on our network of experts for clinical studies in pharmacology,

Read more

PRESSE: Berliner Sonntagsblatt 13.04.2021

Wir freuen uns, dass die Redaktion vom “Berliner Tagesblatt” über unser Konzept berichtet und betont, dass wir vor allem Start-Ups und kleine und mittelständische Unternehmen bei ihren Medizinprodukte- und pharmakologischen Studien in allen Phasen einer klinischen Studie begleiten! Hier geht es zum Artikel: https://www.berliner-sonntagsblatt.de/Research-Experts-Alliance-will-die-klinische-Forschung-revolutionieren-227455.html

pandemic shows the need

The Corona pandemic shows the need for consistent digitization in healthcare industry and accelerates the digital structural change of the German healthcare system in Germany. Companies in the pharmaceutical industry, biotechnology and medical device technology accordingly need strongly digitalized partner for their clinical studies. The network for clinical research Research Experts Alliance (REA) from Berlin

Read more

Research and production

“Research and production must continue to be possible for medium-sized medical technology companies in Germany, and must be promoted and even expanded”, says a recent BVMed paper (Initiative MedTech 2030). In order to improve the conditions for research in Germany, every company should be able to deduct ten per cent of its self-financed expenditure on

Read more